PD-L1 antibody (Extracellular Domain)
Quick Overview for PD-L1 antibody (Extracellular Domain) (ABIN6383847)
Target
See all PD-L1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 39-191, Extracellular Domain
-
Purpose
- PD-L1
-
Purification
- By Protein A from bioreactor concentrate
-
Immunogen
- Recombinant fragment around aa 39-191 of human CD274 protein (exact sequence is proprietary)
-
Isotype
- IgG2b kappa
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
HEK293, HepG2, heart, placenta, spleen, tonsil, carcinomas.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1 mg/mL
-
Buffer
- 1 mg IgG/mL in PBS, 0.05 % azide
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage Comment
- For long term storage, keep small aliquots at -20°C or -80°C and keep one aliquot at 4°C for daily experimentations. Azide will preserve antibody at 4°C for 6-12 months, when kept away from direct sun light.
-
-
- PD-L1 (CD274 (PD-L1))
-
Alternative Name
- CD274
-
Background
- CD274 Molecule, B7-H, B7H1, B7-H1, PD-L1, PDCD1L1, PDCD1LG1, PDL1, Programmed cell death 1 ligand 1, PDCD1 ligand 1, Programmed death ligand 1, B7 homolog 1, CD_antigen: CD274
-
Gene ID
- 29126
-
UniProt
- Q9NZQ7
-
Pathways
- Cancer Immune Checkpoints
Target
-